Abstract
Glycogen synthase kinase-3 (GSK3), a multifunctional serine/threonine kinase, is a key regulator of a number of signaling pathways. Two GSK3 paralogs have been described in mammals: GSK3α and GSK3β, which are 85% homologous to each other and exhibit about 98% homology in the kinase domains and consequently, a high structural similarity. However, some functional differences between both paralogs have been reported. In this work, we review the similarities and differences between GSK3α and GSK3β proteins in relation with their structure and function.
Keywords: GSK3 paralog, polyglycine repeats, kinase inhibitors, glycogen synthase kinases, N- and C-termini, inflammatory response, GSK3 1 phosphorylates phospho-glycogen synthase2 peptide, KESTREL, GSK3, Arg180, Cys205, ATP-binding sites, Dyctiostelium discoidium -catenin, tissue-specific expression, extracellular signals
Current Biotechnology
Title: Structural and Functional Relationships Between GSK3α and GSK3β Proteins
Volume: 1 Issue: 1
Author(s): C. Laura Sayas, Jeronimo Jurado, Jesus Avila and Nieves Villanueva
Affiliation:
Keywords: GSK3 paralog, polyglycine repeats, kinase inhibitors, glycogen synthase kinases, N- and C-termini, inflammatory response, GSK3 1 phosphorylates phospho-glycogen synthase2 peptide, KESTREL, GSK3, Arg180, Cys205, ATP-binding sites, Dyctiostelium discoidium -catenin, tissue-specific expression, extracellular signals
Abstract: Glycogen synthase kinase-3 (GSK3), a multifunctional serine/threonine kinase, is a key regulator of a number of signaling pathways. Two GSK3 paralogs have been described in mammals: GSK3α and GSK3β, which are 85% homologous to each other and exhibit about 98% homology in the kinase domains and consequently, a high structural similarity. However, some functional differences between both paralogs have been reported. In this work, we review the similarities and differences between GSK3α and GSK3β proteins in relation with their structure and function.
Export Options
About this article
Cite this article as:
Laura Sayas C., Jurado Jeronimo, Avila Jesus and Villanueva Nieves, Structural and Functional Relationships Between GSK3α and GSK3β Proteins, Current Biotechnology 2012; 1(1) . https://dx.doi.org/10.2174/2211550111201010080
DOI https://dx.doi.org/10.2174/2211550111201010080 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Translational Applications of Tissue Engineering in Cardiovascular Medicine
Current Pharmaceutical Design Molecular Genetics of Left Ventricular Dysfunction
Current Molecular Medicine Recent Advance in Drug Development of Squamous Cell Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Cardiovascular Benefit of SGLT2 Inhibitors in the Therapeutics of Diabetes Mellitus: A Close Look beyond the Horizon
Current Drug Targets Chemokine-Chemokine Receptor Network in Immune Cell Trafficking
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Editorial: The New Trial EMPAREG-OUTCOMES in Type 2 Diabetes: “and Death Shall Have no Dominion”?
Current Vascular Pharmacology Uptake and Metabolism of the Short-Chain Fatty Acid Butyrate, a Critical Review of the Literature
Current Drug Metabolism Targeted Delivery of Anti-Inflammatory Agents to Tumors
Current Pharmaceutical Design A Review of Statistical and Machine Learning Techniques for Microvascular Complications in Type 2 Diabetes
Current Diabetes Reviews Non-ACE Pathway-induced Angiotensin II Production
Current Pharmaceutical Design Therapeutic Targets for Heart Failure: Beyond Beta-Adrenergic and Renin-Angiotensin System Blockade
Recent Patents on Cardiovascular Drug Discovery Editorial (Thematic Issue: Modifying Cardiovascular Risk Factors: Current Opinion and Future Trends)
Current Pharmaceutical Design Double-Faced Role of Human Mesenchymal Stem Cells and their Role/Challenges in Cancer Therapy
Current Stem Cell Research & Therapy Metformin: Up to Date
Endocrine, Metabolic & Immune Disorders - Drug Targets Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
Current Drug Targets Role of Azoles in Cancer Prevention and Treatment: Present and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry Chronopharmaceuticals: Hype or Future of Pharmaceutics
Current Pharmaceutical Design (Pro)renin Receptor as a New Drug Target
Current Pharmaceutical Design Macrovascular Complications of Type 2 Diabetes Mellitus
Current Vascular Pharmacology The Complex Biology of FOXO
Current Drug Targets